ChemoCentryx, Inc. Announces Transfer of Existing Shares Between Current Stockholders

MOUNTAIN VIEW, Calif., May 25, 2012 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq:CCXI - News) announced today a privately negotiated transfer of 749,999 shares of the Company's common stock between two current stockholders. In connection with this transfer, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., the lead book-running managers in the Company's recent initial public offering of 5.175 million shares of common stock, are waiving the lock-up restriction on those shares which will take effect on May 30, 2012. The purchaser of such shares has agreed with the transferor not to sell or otherwise transfer or dispose of such shares for a period of six months following its acquisition.